Multisistemic Pediatric Inflammatory Syndrome (PIMS) and the association with SARS-CoV-2

Abstract

Introduction: PIMS means pediatric inflammatory multisystemic syndrome. It describes a new health condition seen in children who were infected with new coronaviruses, recovered and later show an immune response that results in significant levels of inflammation in the organ systems and symptoms. Objective: To analyze scientific production on Systemic Pediatric Inflammatory Syndrome (PIMS) in relation to the diagnosis of SARS-CoV-2. Method: The integrative literature review is the method employed for investigation. The following inclusion criteria were adopted: original article in English, available online and in full: year of publication in 2020, in the MEDLINE database, on the PubMed Search Engine. Articles that do not respond to the objective of the study will be excluded. The descriptors applied were: Coronavirus Infections, Syndrome, Child. Results: Five publications were included and categorized in “Scientific production on the correlation of Pediatric Inflammatory Syndrome with SARS-CoV-2”. It showed in the main results that in the analysis of the studies, four studies of children diagnosed with COVID-19 (recent or previous, with past history) developed the syndrome, and that one of the authors links SARS-CoV-2 with Kawasaki Disease (DK) with disagreement. Conclusion: SARS-CoV-2 is related to PIMS, regardless of the development of the syndrome, it can generate serious health complications for the child.